These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10209206)

  • 1. Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs.
    Mobley PW; Waring AJ; Sherman MA; Gordon LM
    Biochim Biophys Acta; 1999 Apr; 1418(1):1-18. PubMed ID: 10209206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
    Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes.
    Mobley PW; Lee HF; Curtain CC; Kirkpatrick A; Waring AJ; Gordon LM
    Biochim Biophys Acta; 1995 Jun; 1271(2-3):304-14. PubMed ID: 7605797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
    Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
    Gordon LM; Curtain CC; Zhong YC; Kirkpatrick A; Mobley PW; Waring AJ
    Biochim Biophys Acta; 1992 Aug; 1139(4):257-74. PubMed ID: 1355364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
    Mobley PW; Barry JA; Waring AJ; Sherman MA; Gordon LM
    AIDS Res Hum Retroviruses; 2007 Feb; 23(2):224-42. PubMed ID: 17331029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
    Pritsker M; Jones P; Blumenthal R; Shai Y
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
    Maddox MW; Longo ML
    Biophys J; 2002 Dec; 83(6):3088-96. PubMed ID: 12496080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy.
    Gordon LM; Mobley PW; Lee W; Eskandari S; Kaznessis YN; Sherman MA; Waring AJ
    Protein Sci; 2004 Apr; 13(4):1012-30. PubMed ID: 15044732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state NMR spectroscopy of the HIV gp41 membrane fusion protein supports intermolecular antiparallel β sheet fusion peptide structure in the final six-helix bundle state.
    Sackett K; Nethercott MJ; Zheng Z; Weliky DP
    J Mol Biol; 2014 Mar; 426(5):1077-94. PubMed ID: 24246500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41.
    Gordon LM; Waring AJ; Curtain CC; Kirkpatrick A; Leung C; Faull K; Mobley PW
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):677-86. PubMed ID: 7576927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
    Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain.
    Sackett K; Shai Y
    J Mol Biol; 2003 Oct; 333(1):47-58. PubMed ID: 14516742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion.
    Sackett K; Shai Y
    Biochemistry; 2002 Apr; 41(14):4678-85. PubMed ID: 11926830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
    Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
    J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.
    Gordon LM; Nisthal A; Lee AB; Eskandari S; Ruchala P; Jung CL; Waring AJ; Mobley PW
    Biochim Biophys Acta; 2008 Oct; 1778(10):2127-37. PubMed ID: 18515070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.
    Sackett K; Nethercott MJ; Epand RF; Epand RM; Kindra DR; Shai Y; Weliky DP
    J Mol Biol; 2010 Mar; 397(1):301-15. PubMed ID: 20080102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes.
    Mobley PW; Curtain CC; Kirkpatrick A; Rostamkhani M; Waring AJ; Gordon LM
    Biochim Biophys Acta; 1992 Aug; 1139(4):251-6. PubMed ID: 1355363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.